XBiotech to Provide Fourth Quarter and Full Year 2016 Business Update
AUSTIN, Texas, 2017-03-09 14:00 CET (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today it will host a conference call and live audio webcast onThursday, March 16, 2017, at8:30 a.m. Eastern Time, to provide an overview of its corporate and clinical activities. The call will encompass developments during the fourth quarter and year endedDecember 31, 2016.
Conference Call Information:
Interested participants and investors may access the conference call by dialing:
- 1 (844) 249-9385 (U.S.)
- 1 (270) 823-1533 (International)
- Conference ID: 81246237
A live audio webcast will also be accessible via the Investors section of theXBiotechwebsitewww.xbiotech.com. The webcast replay will remain available for 90 days.
A telephonic replay of the conference call can be accessed by dialing 1 (855) 859-2056 (U.S.) or 1 (404) 537-3406, and providing the Conference ID: 81246237. The telephonic replay will be available for 24 hours beginning at 11:29 p.m. Eastern TimeonMarch 16, 2017.
XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. XBiotech currently is advancing a robust pipeline of antibody therapies to redefine the standards of care in oncology, inflammatory conditions and infectious diseases. Headquartered in Austin, Texas, XBiotech also is leading the development of innovative biotech manufacturing technologies designed to more rapidly, cost-effectively and flexibly produce new therapies urgently needed by patients worldwide.
Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements, including with respect to the proposed offering of common shares, declarations regarding management's beliefs and expectations that involve substantial risks and uncertainties. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "would," "could," "expects," "plans," "contemplate," "anticipates," "believes," "estimates," "predicts," "projects," "intend" or "continue" or the negative of such terms or other comparable terminology, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to inherent risks and uncertainties in predicting future results and conditions that could cause the actual results to differ materially from those projected in these forward-looking statements. These risks and uncertainties are subject to the disclosures set forth in the "Risk Factors" section of certain of our SEC filings. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
VITEC18.1.2018 21:08 | pressemeddelelse
VITEC to Highlight EZ TV IPTV and Digital Signage Platform in First ISE Appearance
Brookfield Asset Management Inc18.1.2018 16:13 | pressemeddelelse
Brookfield Asset Management Notice of 2017 Year End Results Conference Call and Webcast
LifeSci Advisors, LLC18.1.2018 14:32 | pressemeddelelse
LifeSci Advisors Continues Expansion of U.S. Investor Relations Team with Appointment of Industry Veteran Monique Kosse
Cisco18.1.2018 14:02 | pressemeddelelse
FutureWAN'18 Brings Industry Leaders Together for Global SD-WAN Summit
Renaissance BioScience Corp.18.1.2018 13:01 | pressemeddelelse
Angel Yeast Co., Ltd. signs exclusive global licence agreement with Renaissance BioScience Corp. for wine, cider and craft beer yeast
JD Norman Industries, Inc.18.1.2018 06:02 | pressemeddelelse
JD Norman Industries, Inc. Completes Acquisition of REGE Motorenteile
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum